Bionoid Pharma Inc.
BINP
$0.08
$0.000.00%
OTC PK
| 03/31/2012 | 03/31/2011 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | 284.40K | |||
| Gross Profit | -- | -284.40K | |||
| SG&A Expenses | -- | 8.10M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -- | 9.07M | |||
| Operating Income | -- | -9.07M | |||
| Income Before Tax | -- | -9.09M | |||
| Income Tax Expenses | -- | 3.10K | |||
| Earnings from Continuing Operations | -- | -9.09 | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -- | -9.09M | |||
| EBIT | -- | -9.07M | |||
| EBITDA | -- | -9.04M | |||
| EPS Basic | -- | -652.41 | |||
| Normalized Basic EPS | -- | -407.62 | |||
| EPS Diluted | -- | -652.41 | |||
| Normalized Diluted EPS | -- | -407.62 | |||
| Average Basic Shares Outstanding | -- | 51.70K | |||
| Average Diluted Shares Outstanding | -- | 51.70K | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||